» Articles » PMID: 28485844

Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 2017 May 10
PMID 28485844
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Dynamic thalamic regulation of sensory signals allows the cortex to adjust better to rapidly changing behavioral, physiological, and environmental demands. To fulfill this role, thalamic neurons must themselves be subjected to constantly changing modulatory inputs that originate in multiple neurochemical pathways involved in autonomic, affective, and cognitive functions. This review defines a chemical framework for thinking about the complexity of factors that modulate the response properties of relay trigeminovascular thalamic neurons. Following the presentation of scientific evidence for monosynaptic connections between thalamic trigeminovascular neurons and axons containing glutamate, GABA, dopamine, noradrenaline, serotonin, histamine, orexin, and melanin-concentrating hormone, this review synthesizes a large body of data to propose that the transmission of headache-related nociceptive signals from the thalamus to the cortex is modulated by potentially opposing forces and that the so-called 'decision' of which system (neuropeptide/neurotransmitter) will dominate the firing of a trigeminovascular thalamic neuron at any given time is determined by the constantly changing physiological (sleep, wakefulness, food intake, body temperature, heart rate, blood pressure), behavioral (addiction, isolation), cognitive (attention, learning, memory use), and affective (stress, anxiety, depression, anger) adjustment needed to keep homeostasis.

Citing Articles

Hypothalamic resting-state functional connectivity and self-evaluated aggression in young adults.

Yao Y, Chen Y, Li C J Psychiatr Res. 2025; 182:421-429.

PMID: 39889403 PMC: 11834083. DOI: 10.1016/j.jpsychires.2025.01.045.


Increased Serotonin Levels and Unchanged Glutamate and GABA Levels in Thalamic Microdialysates Despite Reduced Cell Numbers in a Valproic Acid-Induced Autism Model.

Ay H, Horata E, Oncu Kaya E, Korkmaz O Neurochem Res. 2024; 50(1):45.

PMID: 39636522 DOI: 10.1007/s11064-024-04299-2.


Mapping of c-Fos Expression in Rat Brain Sub/Regions Following Chronic Social Isolation: Effective Treatments of Olanzapine, Clozapine or Fluoxetine.

Stanisavljevic Ilic A, Filipovic D Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598437 PMC: 11597560. DOI: 10.3390/ph17111527.


Beyond Pain Relief: Unveiling the Multifaceted Impact of Anti-CGRP/R mAbs on Comorbid Symptoms in Resistant Migraine Patients.

Della Vecchia A, De Luca C, Becattini L, Curto L, Ferrari E, Siciliano G Biomedicines. 2024; 12(3).

PMID: 38540290 PMC: 10968025. DOI: 10.3390/biomedicines12030677.


When the central integrator disintegrates: A review of the role of the thalamus in cognition and dementia.

Biesbroek J, Verhagen M, Van der Stigchel S, Biessels G Alzheimers Dement. 2023; 20(3):2209-2222.

PMID: 38041861 PMC: 10984498. DOI: 10.1002/alz.13563.


References
1.
Guillery R, Sherman S . Thalamic relay functions and their role in corticocortical communication: generalizations from the visual system. Neuron. 2002; 33(2):163-75. DOI: 10.1016/s0896-6273(01)00582-7. View

2.
Burdakov D, Gerasimenko O, Verkhratsky A . Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci. 2005; 25(9):2429-33. PMC: 6726089. DOI: 10.1523/JNEUROSCI.4925-04.2005. View

3.
Green A . Neuropharmacology of 5-hydroxytryptamine. Br J Pharmacol. 2006; 147 Suppl 1:S145-52. PMC: 1760750. DOI: 10.1038/sj.bjp.0706427. View

4.
Fremeau Jr R, Kam K, Qureshi T, Johnson J, Copenhagen D, Storm-Mathisen J . Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science. 2004; 304(5678):1815-9. DOI: 10.1126/science.1097468. View

5.
Homberg J . Serotonin and decision making processes. Neurosci Biobehav Rev. 2011; 36(1):218-36. DOI: 10.1016/j.neubiorev.2011.06.001. View